Glenmark launches Winlevi across key European markets

First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe

Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment

Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe

Akums secures European CEP approval for Cefpodoxime Proxetil

The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner

AbbVie bags major European label expansion for VENCLYXTO in chronic lymphocytic leukemia

The expanded indication is backed by data from the Phase 3 AMPLIFY and GLOW trials and the Phase 2 CAPTIVATE study,

ZIM Laboratories wins European regulatory milestone with anticoagulant approval in Italy

The approval was granted by Agenzia Italiana del Farmaco

Piramal Pharma Solutions appoints Gregory Judge as Director to strengthen European business

In his new role, Gregory will drive partnerships for the company’s large-scale molecule biologics business across Europe

GSK seeks European nod for promising Hepatitis B therapy

GenScript launches first European mRNA production hub in Delft, bolstering EU biotech leadership

Zenex Animal Health makes strategic European play with VievePharm acquisition

VievePharm is renowned for its phytogenic formulations across livestock, equine, and pet care markets

Lupin receives European Commission approval for biosimilar Ranibizumab